![](/img/cover-not-exists.png)
466TiPKEYNOTE-033: Phase 3 study of pembrolizumab versus docetaxel in patients with previously treated non–small-cell lung cancer (NSCLC)
Zhou, C, Caglevic, C, Zhou, J, Wang, B, Wang, K, Ge, J, Zhou, Y, Piperdi, B, Ma, ZVolume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx671.055
Date:
November, 2017
File:
PDF, 42 KB
english, 2017